NCT05177406 Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data Status COMPLETED Phase N/A
NCT05175521 Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine Status COMPLETED Phase NA
NCT05164172 A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine Status RECRUITING Phase PHASE3
NCT05162664 Presence of Signs of Central Sensitization in Episodic and Chronic Migraine Status COMPLETED Phase NA
NCT05161871 Transcranial Direct Current Stimulation Plus Monoclonal Antibodies Acting on the CGRP Pathway for Migraine Status COMPLETED Phase NA
NCT05158894 Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy Status RECRUITING Phase N/A
NCT05156398 Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects Status RECRUITING Phase PHASE3
NCT05133323 A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments Status COMPLETED Phase PHASE2
NCT05127954 Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17) Status ENROLLING_BY_INVITATION Phase PHASE3
NCT05127486 A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine Status COMPLETED Phase PHASE4
NCT05125302 Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) Status RECRUITING Phase PHASE3
NCT05112289 A Study to Evaluate White Matter Hyperintensities in Migraine Status ACTIVE_NOT_RECRUITING Phase NA
NCT05101837 Feasibility and Effectiveness of a Specific App to Delivery Mindfulness Sessions Status COMPLETED Phase PHASE4
NCT05090683 Evaluation of a Mind-body Based Application for the Treatment of Chronic/Persistent Pain. Status COMPLETED Phase NA
NCT05064371 Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan Status COMPLETED Phase PHASE3
NCT05046613 Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant Status RECRUITING Phase N/A
NCT05046522 A Study Evaluating the Effectiveness of PEA Compared to Placebo for Reducing Pain Severity and Duration of Migraines. Status COMPLETED Phase PHASE3